로딩 중…
지수 로딩 중…
IVIM Technology
460470· KOSDAQ· Health Care· Health Care Equipment & Services
₩2,675+2.10%
2026-09-18
Financials
Valuation Metrics
IVIM Technology's Market Cap is ₩404B. At end of 2025 it was ₩497B. Ranked #1899 of 2,421 in KR market (top 78%), #1182 of 1,640 on KOSDAQ (top 72%), #80 of 96 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 40.44B KRW | KR#1,899/2,421 Sec#80/96 |
| Revenue | 6.56B KRW | KR#2,318/2,421 Sec#84/96 |
| Net Income | -2.68B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 28.72B KRW | KR#2,346/2,421 Sec#90/96 |
| Net Assets | 26.17B KRW | KR#2,216/2,421 Sec#80/96 |
| Employees | 37 | KR#2,154/2,421 Sec#85/96 |
| Value | ||
| P/B | 1.55x | KR#1,786/2,421 Sec#60/96 |
| P/S | 6.17x | KR#2,196/2,421 Sec#78/96 |
| FCF Yield | -16.56% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -10.25% | KR#1,946/2,421 Sec#68/96 |
| ROA | -9.34% | KR#2,086/2,421 Sec#73/96 |
| Op. Margin | -47.27% | KR#2,230/2,421 Sec#77/96 |
| Revenue Growth | 22.77% | KR#505/2,421 Sec#26/96 |
| Financial Health | ||
| Debt Ratio | 9.75% | KR#135/2,421 Sec#8/96 |
| Total Debt | 791.3M KRW | KR#1,983/2,421 Sec#78/96 |
| FCF | -6.70B KRW | KR#1,578/2,421 Sec#54/96 |
| Cash | 4.60B KRW | KR#2,029/2,421 Sec#73/96 |
| Current Ratio | 18.66x | KR#31/2,421 Sec#3/96 |
| Performance | ||
| 1Y Return | -12.44% | KR#1,029/2,421 Sec#20/96 |
| 1M Return | -7.76% | KR#1,986/2,421 Sec#71/96 |
| From 52W High | -45.91% | KR#1,206/2,421 Sec#39/96 |
| 1Y MDD | -46.68% | KR#840/2,421 Sec#27/96 |
| Trading | ||
| Volume | 15,159 shares | KR#1,727/2,421 Sec#66/96 |
| Trading Value | 39.6M KRW | KR#1,926/2,421 Sec#77/96 |
| Foreign Own. | 1.28% | KR#1,924/2,421 Sec#70/96 |
| Per Share | ||
| EPS | -177 KRW | KR—/2,421 Sec—/96 |
| BPS | 1,731 KRW | KR#2,134/2,421 Sec#74/96 |
Company Info
IVIMTechnology Co., Ltd. specializes in pioneering solutions for the concurrent imaging of cells and bio-drugs within the diverse tissues and organs of living organisms. Its product line includes models like IVM-C3, IVM-M3, IVM-CM3, and IVM-MS3. The company was established on June 23, 2017, by co-founders Kim Pil-Han and Kim In-Sun, and is based in Daejeon, South Korea.